Stock data
Anika Therapeutics Inc. (ANIK)
Anika Therapeutics Inc. (ANIK) reported revenue of US$112.82M and net income of -US$10.88M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$112.82M | US$63.81M | -US$11.05M | -US$10.88M | — |
| 2024 | US$119.91M | US$76.00M | -US$5.10M | -US$56.38M | — |
| 2023 | US$120.79M | US$82.53M | US$0.84M | -US$82.67M | — |
| 2022 | US$113.83M | US$73.22M | US$3.67M | -US$14.86M | — |
| 2021 | US$147.79M | US$82.94M | US$2.62M | US$4.13M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$32.61M | US$3.31M | — |
| 2026-03-31 | US$29.61M | -US$5.06M | — |
| 2025-12-31 | US$30.61M | US$0.29M | — |
| 2025-09-30 | US$27.82M | -US$2.33M | — |
| 2025-06-30 | US$28.22M | -US$3.97M | — |
| 2025-03-31 | US$26.17M | -US$4.87M | — |
| 2024-12-31 | US$30.60M | -US$21.86M | — |
| 2024-09-30 | US$29.56M | -US$29.92M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.